Influenza vaccination rate among patients with moderate to severe psoriasis;Inanspruchnahme der Grippeschutzimpfung bei Patienten mit mittelschwerer oder schwerer Psoriasis

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue 9, 2013, Pages 837-844

  Radtke, Marc Alexander ^a   Rustenbach, Stephan Jeff ^a   Reusch, Michael ^b   Strömer, Klaus ^c   Augustin, Matthias ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Dermatologic Practice   (Germany)

^c Dermatologe/Allergologe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DERMATOLOGIST; DISEASE SEVERITY; FEMALE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PREVALENCE; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIATIC ARTHRITIS; QUALITY OF LIFE INDEX; QUESTIONNAIRE; SEASONAL VARIATION; TREATMENT REFUSAL;

ADULT; AGED; AGED, 80 AND OVER; CAUSALITY; COMORBIDITY; FEMALE; GERMANY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME; VACCINATION; YOUNG ADULT;

EID: 84883484086     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12010     Document Type: Article

References (18)

1. Bridges CB, Katz JM, Levandowski RA, Cox NJ,. Inactivated influenza vaccines. In:, Plotkin S, Orenstein W, Offit P, editors: Vaccines, 5th edition, New York: Elsevier, 2008; 259-90.
2. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ,. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56: 1-54.
3. Rothberg MB, Haessler SD, Brown RB,. Complications of viral influenza. Am J Med 2008; 121: 258-64.
4. Almond MH, McAuley DF, Wise MP, Griffiths MJ,. Influenza-related pneumonia. Clin Med 2012; 12: 67-70.
5. Blyth CC, Webb SA, Kok J, Dwyer DE, van Hal SJ, Foo H, Ginn AN, Kesson AM, Seppelt I, Iredell JR,; on behalf of the ANZIC Influenza Investigators and COSI Microbiological Investigators. The impact of bacterial and viral co-infection in severe influenza. Influenza Other Respi Viruses 2013; 7: 168-76.
6. Wiese-Posselt M, Tertilt C, Zepp F,. Vaccination recommendations for Germany. Dtsch Ärztebl Int 2011; 108: 771-9.
7. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M,. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-51.
8. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I,. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010; 162: 633-6.
9. Jamnitski A, Symmons D, Peters MJ, Sattar N, McIinnes I, Nurmohamed MT,. Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2012; 72: 211-6.
10. Daudén E, Castañeda S, Suárez C, García- Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL,; Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis. Integrated approach to comorbidity in patients with psoriasis. Actas Dermosifiliogr 2012; 103: 1-64.
11. Augustin M, Reich K, Reich C, Purwins S, Jeff Rustenbach S, Schäfer I, Radtke M,. Quality of psoriasis care in Germany-results of the national study PsoHealth 2007. J Dtsch Dermatol Ges 2008; 6: 640-5.
12. Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Müller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B,; Deutsche Dermatologische Gesellschaft; Berufsverband Deutscher Dermatologen. German S3-guidelines on the treatment of psoriasis vulgaris (short version). Arch Dermatol Res 2012; 304: 87-113.
13. Böhmer MM, Walter D, Müters S, Krause G, Wichmann O,. Seasonal influenza vaccine uptake in Germany 2007/2008 and 2008/2009: Results from a national health update survey. Vaccine 2011; 29: 4492-8.
14. Teich N, Klugmann T, Tiedemann A, Holler B, Mössner J, Liebetrau A, Schiefke,. Impfschutz bei Immunsupprimierten. Dtsch Ärztebl 2011; 7: 105-11.
15. Melmed GY, Ippoliti AF, Papadakis KA,. Patients with imflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006; 101: 1834-40.
16. Haroon M, Adeeb F, Eltahir A, Harney S,. The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatients clinics. Joint Bone Spine 2001; 78: 374-7.
17. Roggendorf H, Sprave T, Hertel S, Morscheck F, Roggendorf M,. Rate of influenza vaccination among medical staff working at a university hospital. Dtsch Med Wochenschr 2011; 136: 1299-304.
18. The Council of the European Union. Council Recommendation of 22 December 2009 on seasonal influenza vaccination Official Journal of the European Union 2009; 52: 71-2.